What is MICROCHIP TECHNOLOGY INC.'s earnings per share (EPS)?

MICROCHIP TECHNOLOGY INC. (MCHPP) reported diluted earnings per share of $0.22 for fiscal year 2026. This represents a 2300.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

MICROCHIP TECHNOLOGY INC. Financials

MCHPP

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE March

This page shows MICROCHIP TECHNOLOGY INC. (MCHPP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MCHPP FY2025 2026-04-22

MCHPP’s earnings collapsed faster than cash generation because heavy noncash expense and light reinvestment still supported free cash flow.

From FY2024 to FY2025, operating margin fell from 33.7% to 6.7%, yet free cash flow stayed positive because capex remained small relative to depreciation and receivables fell with sales. That means the income statement deteriorated much faster than the company’s near-term cash extraction from its existing asset base did.

The liquidity picture improved even in a weak year: cash reached $772M and the current ratio rose to 2.6x while total liabilities continued to decline. That points to short-term balance-sheet flexibility, because the company did not need a jump in payables or fresh borrowing to defend liquidity during the downturn.

A goodwill-heavy balance sheet remained anchored near $6.7B as revenue shrank, so return on assets was squeezed toward break-even rather than cushioned by asset reductions. In practice, the reported asset base looks much stickier than the sales line, so a revenue shock shows up first in returns and margins rather than in a quickly shrinking balance sheet.

Financial Health Signals

Financial Profile 47/100

Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of MICROCHIP TECHNOLOGY INC.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

MICROCHIP TECHNOLOGY INC. has an operating margin of 10.4%, meaning the company retains $10 of operating profit per $100 of revenue. This results in a moderate score of 53/100, indicating healthy but not exceptional operating efficiency. This is up from 6.7% the prior year.

Growth

MICROCHIP TECHNOLOGY INC.'s revenue grew 7.1% year-over-year to $4.7B, a solid pace of expansion. This earns a growth score of 0/100.

Leverage

MICROCHIP TECHNOLOGY INC. carries a low D/E ratio of 0.85, meaning only $0.85 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 85/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

MICROCHIP TECHNOLOGY INC.'s current ratio of 2.09 indicates adequate short-term liquidity, earning a score of 38/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

MICROCHIP TECHNOLOGY INC. converts 18.5% of revenue into free cash flow ($871.0M). This strong cash generation earns a score of 78/100.

Returns

MICROCHIP TECHNOLOGY INC. generates a 3.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 28/100. This is up from -0.0% the prior year.

Piotroski F-Score Neutral

6/9

MICROCHIP TECHNOLOGY INC. passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed

4.18x

For every $1 of reported earnings, MICROCHIP TECHNOLOGY INC. generates $4.18 in operating cash flow ($962.1M OCF vs $230.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

2.2x

MICROCHIP TECHNOLOGY INC. earns $2.2 in operating income for every $1 of interest expense ($490.1M vs $221.3M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$4.7B

YoY+7.1%

5Y CAGR-2.8%

10Y CAGR+8.0%

MICROCHIP TECHNOLOGY INC. generated $4.7B in revenue in fiscal year 2026. This represents an increase of 7.1% from the prior year.

EBITDA

$1.2B

YoY+12.7%

5Y CAGR-11.3%

10Y CAGR+6.4%

MICROCHIP TECHNOLOGY INC.'s EBITDA was $1.2B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 12.7% from the prior year.

Net Income

$230.0M

YoY+46100.0%

5Y CAGR-8.0%

10Y CAGR-3.4%

MICROCHIP TECHNOLOGY INC. reported $230.0M in net income in fiscal year 2026. This represents an increase of 46100.0% from the prior year.

EPS (Diluted)

$0.22

YoY+2300.0%

5Y CAGR-19.5%

10Y CAGR-17.4%

MICROCHIP TECHNOLOGY INC. earned $0.22 per diluted share (EPS) in fiscal year 2026. This represents an increase of 2300.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$871.0M

YoY+12.8%

5Y CAGR-13.7%

10Y CAGR+1.7%

MICROCHIP TECHNOLOGY INC. generated $871.0M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 12.8% from the prior year.

Cash & Debt

$240.3M

YoY-68.9%

5Y CAGR-3.0%

10Y CAGR-19.5%

MICROCHIP TECHNOLOGY INC. held $240.3M in cash against $5.5B in long-term debt as of fiscal year 2026.

Dividends Per Share

$1.82

YoY+0.2%

5Y CAGR+19.5%

10Y CAGR+2.4%

MICROCHIP TECHNOLOGY INC. paid $1.82 per share in dividends in fiscal year 2026. This represents an increase of 0.2% from the prior year.

Shares Outstanding

542M

YoY+0.5%

5Y CAGR+14.7%

10Y CAGR+10.3%

MICROCHIP TECHNOLOGY INC. had 542M shares outstanding in fiscal year 2026. This represents an increase of 0.5% from the prior year.

Margins & Returns

Gross Margin

57.7%

YoY+1.7pp

5Y CAGR-4.4pp

10Y CAGR+2.3pp

MICROCHIP TECHNOLOGY INC.'s gross margin was 57.7% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 1.7 percentage points from the prior year.

Operating Margin

10.4%

YoY+3.7pp

5Y CAGR-8.0pp

10Y CAGR-5.8pp

MICROCHIP TECHNOLOGY INC.'s operating margin was 10.4% in fiscal year 2026, reflecting core business profitability. This is up 3.7 percentage points from the prior year.

Net Margin

4.9%

YoY+4.9pp

5Y CAGR-1.5pp

10Y CAGR-10.0pp

MICROCHIP TECHNOLOGY INC.'s net profit margin was 4.9% in fiscal year 2026, showing the share of revenue converted to profit. This is up 4.9 percentage points from the prior year.

Return on Equity

3.6%

YoY+3.6pp

5Y CAGR-3.0pp

MICROCHIP TECHNOLOGY INC.'s ROE was 3.6% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 3.6 percentage points from the prior year.

Capital Allocation

R&D Spending

$1.1B

YoY+10.4%

5Y CAGR+5.4%

10Y CAGR+11.3%

MICROCHIP TECHNOLOGY INC. invested $1.1B in research and development in fiscal year 2026. This represents an increase of 10.4% from the prior year.

Share Buybacks

YoY-100.0%

MICROCHIP TECHNOLOGY INC. spent $0 on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.

Capital Expenditures

$91.1M

YoY-27.7%

5Y CAGR-0.3%

10Y CAGR+29.1%

MICROCHIP TECHNOLOGY INC. invested $91.1M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 27.7% from the prior year.

MCHPP Income Statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Revenue	$4.7B+7.1%	$4.4B-42.3%	$7.6B-9.5%	$8.4B+23.7%	$6.8B+25.4%	$5.4B
Cost of Revenue	$2.0B+3.0%	$1.9B-26.7%	$2.6B-3.7%	$2.7B+15.6%	$2.4B+15.1%	$2.1B
Gross Profit	$2.7B+10.3%	$2.5B-50.6%	$5.0B-12.3%	$5.7B+28.1%	$4.4B+31.7%	$3.4B
R&D Expenses	$1.1B+10.4%	$983.8M-10.4%	$1.1B-1.9%	$1.1B+13.1%	$989.1M+18.3%	$836.4M
SG&A Expenses	$674.3M+9.2%	$617.7M-15.9%	$734.2M-8.0%	$797.7M+11.0%	$718.9M+17.8%	$610.3M
Operating Income	$490.1M+65.4%	$296.3M-88.5%	$2.6B-17.5%	$3.1B+68.5%	$1.8B+85.3%	$998.1M
Interest Expense	$221.3M-14.6%	$259.2M+30.7%	$198.3M-2.7%	$203.9M-20.7%	$257.0M-28.0%	$356.9M
Income Tax	$43.5M+10.4%	$39.4M-91.4%	$459.0M-31.7%	$672.0M+241.1%	$197.0M+2089.9%	-$9.9M
Net Income	$230.0M+46100.0%	-$500K-100.0%	$1.9B-14.8%	$2.2B+74.1%	$1.3B+267.9%	$349.4M
EPS (Diluted)	$0.22+2300.0%	$-0.01-100.3%	$3.48-13.4%	$4.02+77.1%	$2.27+249.2%	$0.65

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Revenue	$1.3B+10.6%	$1.2B+4.0%	$1.1B+6.0%	$1.1B+10.8%	$970.5M-5.4%	$1.0B-11.8%	$1.2B-6.2%	$1.2B
Cost of Revenue	$511.6M+6.8%	$479.1M-4.7%	$502.5M+0.7%	$498.8M+6.3%	$469.4M+1.0%	$464.6M-6.2%	$495.3M-1.8%	$504.4M
Gross Profit	$799.6M+13.1%	$706.9M+10.8%	$637.9M+10.6%	$576.7M+15.1%	$501.1M-10.7%	$561.4M-16.0%	$668.5M-9.3%	$736.9M
R&D Expenses	$293.8M+7.1%	$274.3M+4.6%	$262.3M+2.7%	$255.5M+0.1%	$255.2M+3.7%	$246.2M+2.3%	$240.7M-0.4%	$241.7M
SG&A Expenses	$174.2M+3.4%	$168.5M-2.2%	$172.3M+8.2%	$159.3M+4.8%	$152.0M-3.9%	$158.2M+0.8%	$157.0M+4.3%	$150.5M
Operating Income	$217.4M+43.3%	$151.7M+70.6%	$88.9M+176.9%	$32.1M+132.0%	-$100.3M-424.6%	$30.9M-78.9%	$146.6M-33.1%	$219.1M
Interest Expense	$51.7M-7.5%	$55.9M-0.7%	$56.3M-1.9%	$57.4M-17.5%	$69.6M+1.3%	$68.7M+16.2%	$59.1M-4.4%	$61.8M
Income Tax	$19.7M-36.2%	$30.9M+412.1%	-$9.9M-453.6%	$2.8M+120.4%	-$13.7M-282.7%	$7.5M-42.7%	$13.1M-59.7%	$32.5M
Net Income	$144.2M+130.0%	$62.7M+50.4%	$41.7M+324.2%	-$18.6M+88.0%	-$154.6M-188.4%	-$53.6M-168.4%	$78.4M-39.4%	$129.3M
EPS (Diluted)	N/A	$0.06+100.0%	$0.03+133.3%	$-0.09	N/A	$-0.10-171.4%	$0.14-41.7%	$0.24

MCHPP Balance Sheet

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Total Assets	$14.4B-6.5%	$15.4B-3.1%	$15.9B-3.0%	$16.4B+1.1%	$16.2B-1.7%	$16.5B
Current Assets	$2.4B-20.5%	$3.0B-0.7%	$3.0B-1.8%	$3.1B+25.1%	$2.5B+14.3%	$2.1B
Cash & Equivalents	$240.3M-68.9%	$771.7M+141.4%	$319.7M+36.6%	$234.0M-26.3%	$317.4M+13.4%	$280.0M
Inventory	$1.0B-20.0%	$1.3B-1.7%	$1.3B-0.7%	$1.3B+55.1%	$854.4M+28.5%	$665.0M
Accounts Receivable	$894.7M+29.7%	$689.7M-39.7%	$1.1B-12.4%	$1.3B+21.7%	$1.1B+7.5%	$997.7M
Goodwill	$6.7B+0.2%	$6.7B+0.1%	$6.7B0.0%	$6.7B0.0%	$6.7B0.0%	$6.7B
Total Liabilities	$7.9B-4.3%	$8.3B-10.0%	$9.2B-6.5%	$9.9B-4.3%	$10.3B-7.5%	$11.1B
Current Liabilities	$1.1B-1.6%	$1.2B-54.2%	$2.5B-19.2%	$3.1B+122.9%	$1.4B-41.9%	$2.4B
Long-Term Debt	$5.5B-2.4%	$5.6B+12.6%	$5.0B-0.8%	$5.0B-34.4%	$7.7B+1.4%	$7.6B
Total Equity	$6.4B-9.1%	$7.1B+6.3%	$6.7B+2.2%	$6.5B+10.5%	$5.9B+10.4%	$5.3B
Retained Earnings	$4.9B-15.0%	$5.8B-14.5%	$6.8B+17.3%	$5.8B+38.1%	$4.2B+23.0%	$3.4B

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Total Assets	$14.4B+0.3%	$14.3B-1.0%	$14.5B-3.4%	$15.0B-2.6%	$15.4B-1.6%	$15.6B+0.1%	$15.6B-1.4%	$15.8B
Current Assets	$2.4B+3.8%	$2.3B-2.5%	$2.4B-14.7%	$2.8B-7.9%	$3.0B-0.2%	$3.0B+3.1%	$2.9B-1.5%	$2.9B
Cash & Equivalents	$240.3M-4.1%	$250.7M+5.9%	$236.8M-58.2%	$566.5M-26.6%	$771.7M+31.7%	$586.0M+104.8%	$286.1M-9.2%	$315.1M
Inventory	$1.0B-2.1%	$1.1B-3.4%	$1.1B-6.3%	$1.2B-9.6%	$1.3B-4.6%	$1.4B+1.2%	$1.3B+2.4%	$1.3B
Accounts Receivable	$894.7M+22.4%	$731.2M-2.0%	$746.2M-2.5%	$765.5M+11.0%	$689.7M-19.5%	$857.2M-17.9%	$1.0B-4.7%	$1.1B
Goodwill	$6.7B0.0%	$6.7B0.0%	$6.7B0.0%	$6.7B+0.2%	$6.7B0.0%	$6.7B0.0%	$6.7B0.0%	$6.7B
Total Liabilities	$7.9B+2.2%	$7.8B-0.1%	$7.8B-4.3%	$8.1B-2.1%	$8.3B-13.6%	$9.6B+2.7%	$9.3B-0.9%	$9.4B
Current Liabilities	$1.1B+7.3%	$1.1B+1.5%	$1.0B-12.3%	$1.2B+3.1%	$1.2B-13.2%	$1.3B-59.5%	$3.3B+116.1%	$1.5B
Long-Term Debt	$5.5B+2.4%	$5.4B-0.2%	$5.4B-1.5%	$5.5B-3.1%	$5.6B-16.6%	$6.7B+50.8%	$4.5B-27.4%	$6.2B
Total Equity	$6.4B-2.0%	$6.6B-2.0%	$6.7B-2.4%	$6.9B-3.1%	$7.1B+17.4%	$6.0B-3.9%	$6.3B-2.0%	$6.4B
Retained Earnings	$4.9B-2.6%	$5.0B-4.0%	$5.3B-4.2%	$5.5B-5.0%	$5.8B-6.5%	$6.2B-4.6%	$6.5B-2.5%	$6.6B

MCHPP Cash Flow Statement

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Operating Cash Flow	$962.1M+7.1%	$898.1M-69.0%	$2.9B-20.1%	$3.6B+27.4%	$2.8B+48.3%	$1.9B
Capital Expenditures	$91.1M-27.7%	$126.0M-55.8%	$285.1M-41.4%	$486.2M+31.4%	$370.1M+299.7%	$92.6M
Free Cash Flow	$871.0M+12.8%	$772.1M-70.4%	$2.6B-16.8%	$3.1B+26.8%	$2.5B+35.6%	$1.8B
Investing Cash Flow	-$195.5M+32.1%	-$287.8M+26.6%	-$392.1M+34.6%	-$599.5M-25.5%	-$477.7M-175.6%	-$173.3M
Financing Cash Flow	-$1.3B-720.0%	-$158.3M+93.4%	-$2.4B+22.2%	-$3.1B-33.4%	-$2.3B-24.9%	-$1.9B
Dividends Paid	$984.0M+0.9%	$975.7M+7.0%	$911.5M	N/A	N/A	N/A
Share Buybacks	$0-100.0%	$96.5M-90.2%	$982.1M+3.8%	$945.8M+122.2%	$425.6M	$0

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Operating Cash Flow	$257.0M-24.7%	$341.4M+287.5%	$88.1M-68.0%	$275.6M+33.9%	$205.9M-24.2%	$271.5M+522.7%	$43.6M-88.4%	$377.1M
Capital Expenditures	$14.2M-36.9%	$22.5M-38.4%	$36.5M+103.9%	$17.9M+26.1%	$14.2M-21.5%	$18.1M-13.0%	$20.8M-71.5%	$72.9M
Free Cash Flow	$242.8M-23.9%	$318.9M+518.0%	$51.6M-80.0%	$257.7M+34.4%	$191.7M-24.3%	$253.4M+1011.4%	$22.8M-92.5%	$304.2M
Investing Cash Flow	-$52.1M-17.1%	-$44.5M+28.2%	-$62.0M-68.0%	-$36.9M+34.1%	-$56.0M-33.0%	-$42.1M+34.4%	-$64.2M+48.8%	-$125.5M
Financing Cash Flow	-$215.3M+23.9%	-$283.0M+20.5%	-$355.8M+19.8%	-$443.9M-1339.9%	$35.8M-49.2%	$70.5M+939.3%	-$8.4M+96.7%	-$256.2M
Dividends Paid	$246.6M+0.2%	$246.1M+0.1%	$245.8M+0.1%	$245.5M+0.3%	$244.8M+0.1%	$244.6M+0.4%	$243.7M+0.5%	$242.6M
Share Buybacks	$0	$0	$0	$0	$0-100.0%	$6.5M-62.4%	$17.3M-76.2%	$72.7M

MCHPP Financial Ratios

Metric	FY26	FY25	FY24	FY23	FY22	FY21
Gross Margin	57.7%+1.7pp	56.1%-9.4pp	65.4%-2.1pp	67.5%+2.3pp	65.2%+3.1pp	62.1%
Operating Margin	10.4%+3.7pp	6.7%-26.9pp	33.7%-3.3pp	36.9%+9.8pp	27.1%+8.8pp	18.4%
Net Margin	4.9%+4.9pp	-0.0%-25.0pp	25.0%-1.5pp	26.5%+7.7pp	18.9%+12.4pp	6.4%
Return on Equity	3.6%+3.6pp	-0.0%-28.6pp	28.6%-5.7pp	34.4%+12.5pp	21.8%+15.3pp	6.6%
Return on Assets	1.6%+1.6pp	0.0%-12.0pp	12.0%-1.7pp	13.7%+5.7pp	7.9%+5.8pp	2.1%
Current Ratio	2.09-0.5	2.59+1.4	1.20+0.2	0.98-0.8	1.75+0.9	0.89
Debt-to-Equity	0.85+0.1	0.80+0.0	0.75-0.0	0.77-0.5	1.30-0.1	1.42
FCF Margin	18.5%+0.9pp	17.5%-16.6pp	34.2%-3.0pp	37.1%+0.9pp	36.3%+2.7pp	33.5%

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Gross Margin	61.0%+1.4pp	59.6%+3.7pp	55.9%+2.3pp	53.6%+2.0pp	51.6%-3.1pp	54.7%-2.7pp	57.4%-1.9pp	59.4%
Operating Margin	16.6%+3.8pp	12.8%+5.0pp	7.8%+4.8pp	3.0%+13.3pp	-10.3%-13.3pp	3.0%-9.6pp	12.6%-5.0pp	17.6%
Net Margin	11.0%+5.7pp	5.3%+1.6pp	3.7%+5.4pp	-1.7%+14.2pp	-15.9%-10.7pp	-5.2%-12.0pp	6.7%-3.7pp	10.4%
Return on Equity	2.2%+1.3pp	1.0%+0.3pp	0.6%+0.9pp	-0.3%+1.9pp	-2.2%-1.3pp	-0.9%-2.1pp	1.3%-0.8pp	2.0%
Return on Assets	1.0%+0.6pp	0.4%+0.2pp	0.3%+0.4pp	-0.1%+0.9pp	-1.0%-0.7pp	-0.3%-0.8pp	0.5%-0.3pp	0.8%
Current Ratio	2.09-0.1	2.16-0.1	2.25-0.1	2.31-0.3	2.59+0.3	2.25+1.4	0.88-1.1	1.94
Debt-to-Equity	0.85+0.0	0.82+0.0	0.800.0	0.800.0	0.80-0.3	1.12+0.4	0.71-0.2	0.96
FCF Margin	18.5%-8.4pp	26.9%+22.4pp	4.5%-19.4pp	24.0%+4.2pp	19.8%-4.9pp	24.7%+22.7pp	2.0%-22.6pp	24.5%

Frequently Asked Questions

What is MICROCHIP TECHNOLOGY INC.'s annual revenue?

MICROCHIP TECHNOLOGY INC. (MCHPP) reported $4.7B in total revenue for fiscal year 2026. This represents a 7.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is MICROCHIP TECHNOLOGY INC.'s revenue growing?

MICROCHIP TECHNOLOGY INC. (MCHPP) revenue grew by 7.1% year-over-year, from $4.4B to $4.7B in fiscal year 2026.

Is MICROCHIP TECHNOLOGY INC. profitable?

Yes, MICROCHIP TECHNOLOGY INC. (MCHPP) reported a net income of $230.0M in fiscal year 2026, with a net profit margin of 4.9%.

What is MICROCHIP TECHNOLOGY INC.'s EBITDA?

MICROCHIP TECHNOLOGY INC. (MCHPP) had EBITDA of $1.2B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does MICROCHIP TECHNOLOGY INC. have?

As of fiscal year 2026, MICROCHIP TECHNOLOGY INC. (MCHPP) had $240.3M in cash and equivalents against $5.5B in long-term debt.

What is MICROCHIP TECHNOLOGY INC.'s gross margin?

MICROCHIP TECHNOLOGY INC. (MCHPP) had a gross margin of 57.7% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is MICROCHIP TECHNOLOGY INC.'s operating margin?

MICROCHIP TECHNOLOGY INC. (MCHPP) had an operating margin of 10.4% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is MICROCHIP TECHNOLOGY INC.'s net profit margin?

MICROCHIP TECHNOLOGY INC. (MCHPP) had a net profit margin of 4.9% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Does MICROCHIP TECHNOLOGY INC. pay dividends?

Yes, MICROCHIP TECHNOLOGY INC. (MCHPP) paid $1.82 per share in dividends during fiscal year 2026.

What is MICROCHIP TECHNOLOGY INC.'s return on equity (ROE)?

MICROCHIP TECHNOLOGY INC. (MCHPP) has a return on equity of 3.6% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is MICROCHIP TECHNOLOGY INC.'s free cash flow?

MICROCHIP TECHNOLOGY INC. (MCHPP) generated $871.0M in free cash flow during fiscal year 2026. This represents a 12.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is MICROCHIP TECHNOLOGY INC.'s operating cash flow?

MICROCHIP TECHNOLOGY INC. (MCHPP) generated $962.1M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are MICROCHIP TECHNOLOGY INC.'s total assets?

MICROCHIP TECHNOLOGY INC. (MCHPP) had $14.4B in total assets as of fiscal year 2026, including both current and long-term assets.

What are MICROCHIP TECHNOLOGY INC.'s capital expenditures?

MICROCHIP TECHNOLOGY INC. (MCHPP) invested $91.1M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does MICROCHIP TECHNOLOGY INC. spend on research and development?

MICROCHIP TECHNOLOGY INC. (MCHPP) invested $1.1B in research and development during fiscal year 2026.

How many shares does MICROCHIP TECHNOLOGY INC. have outstanding?

MICROCHIP TECHNOLOGY INC. (MCHPP) had 542M shares outstanding as of fiscal year 2026.

What is MICROCHIP TECHNOLOGY INC.'s current ratio?

MICROCHIP TECHNOLOGY INC. (MCHPP) had a current ratio of 2.09 as of fiscal year 2026, which is generally considered healthy.

What is MICROCHIP TECHNOLOGY INC.'s debt-to-equity ratio?

MICROCHIP TECHNOLOGY INC. (MCHPP) had a debt-to-equity ratio of 0.85 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is MICROCHIP TECHNOLOGY INC.'s return on assets (ROA)?

MICROCHIP TECHNOLOGY INC. (MCHPP) had a return on assets of 1.6% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is MICROCHIP TECHNOLOGY INC.'s Piotroski F-Score?

MICROCHIP TECHNOLOGY INC. (MCHPP) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are MICROCHIP TECHNOLOGY INC.'s earnings high quality?

MICROCHIP TECHNOLOGY INC. (MCHPP) has an earnings quality ratio of 4.18x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can MICROCHIP TECHNOLOGY INC. cover its interest payments?

MICROCHIP TECHNOLOGY INC. (MCHPP) has an interest coverage ratio of 2.2x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is MICROCHIP TECHNOLOGY INC.?

MICROCHIP TECHNOLOGY INC. (MCHPP) scores 47 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.